According to a study conducted by researchers at Banaras Hindu University and published in Springer Nature, adolescent girls are at risk of adverse events after receiving Covaxin.
A recent report published in Springer Nature indicates that adolescent girls and individuals with co-morbidities are at a higher risk of adverse events after receiving Bharat Biotech’s BBV152 (Covaxin) COVID-19 vaccine. According to the report, nearly one-third of participants in an observational study on the vaccine experienced adverse events of special interest (AESI).
The study, titled “Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a one-year prospective study in North India,” was conducted by researchers at Banaras Hindu University. It also noted that serious adverse events might occur in 1% of BBV152 recipients, highlighting the need for extended surveillance following vaccination.
In response to a query from The Hindu, Bharat Biotech stated that certain data points were necessary to ensure the safety study was informative and free from investigator bias. The company also mentioned that numerous studies on Covaxin’s safety have been conducted and published in peer-reviewed journals, demonstrating an excellent safety record.
The study, which enrolled 1,024 individuals, successfully followed up with 635 adolescents and 291 adults over a year. It found that viral upper respiratory tract infections were reported by 304 adolescents (47.9%) and 124 adults (42.6%).
Among adolescents, the most common adverse events of special interest (AESI) were new-onset skin and subcutaneous disorders (10.5%), general disorders (10.2%), and nervous system disorders (4.7%). In adults, the common AESI were general disorders (8.9%), musculoskeletal disorders (5.8%), and nervous system disorders (5.5%). Additionally, menstrual abnormalities were observed in 4.6% of female participants.
GreatGameIndia reported that in a preprint, Japanese scientists warn against blood transfusions from mRNA vaccine recipients, claiming that there are various possible complications linked to blood transfusions from people who have received mRNA COVID-19 shots.
